| 輔英科技大學 |
2013-03-16 |
Increased pre-mir-133a expression associated with poor prognosis in Taiwanese breast cancer
|
葉耀宗 |
| 輔英科技大學 |
2013-03-13 |
Study the underlying mechanisms and potential roles of activated Mitogen-activated Protein Kinase Kinase 4 (p-MKK4) in breast cancer metastasis
|
葉耀宗 |
| 高雄醫學大學 |
2013 |
咖啡因參與調節脂肪幹細胞和骨髓基質幹細胞的骨分化及礦化作用
|
蘇淑真;張基隆;蘇淑慧;葉耀宗;徐慧文;陳冠銘 ; Su, SJ;Chang, KL;Su, SH;Yeh, YT;Shyu, HW;Chen, KM. |
| 輔英科技大學 |
2012-09-21 |
HDAC2 promotes the nuclear translocation of HER-2/neu and induced the expression of COX-2 in breast cancer
|
葉耀宗 |
| 輔英科技大學 |
2012-05-25 |
Interplay of HDAC6 with progesterone signaling in breast cancer
|
葉耀宗 |
| 輔英科技大學 |
2012-05-25 |
Novel peptide mimics targeting Nibrin inhibit tumor growth of liver cancer cells
|
葉耀宗 |
| 輔英科技大學 |
2012-05-25 |
PIAS3 and its interplay with estrogen receptor in breast cancer
|
葉耀宗 |
| 輔英科技大學 |
2012-05-18 |
Increased HDAC8 protein associates with poor survival of breast cancer patients
|
葉耀宗 |
| 輔英科技大學 |
2012-05-18 |
Lignad-like peptide mimic enhanced the cytotoxicity of medroxylprogesterone and mgesterol acetate toward liver cancer cells
|
葉耀宗 |
| 輔英科技大學 |
2012-01-08 |
配位子樣擬胜?抗癌藥物之開發及其在肝癌治療上之應用
|
葉耀宗 |
| 高雄醫學大學 |
2012 |
Decreased Total MKP-1 Protein Levels Predict Poor Prognosis
|
侯明鋒;張建偉;陳芳銘;王森稔;楊曉芳;陳柏翰;蘇鈞煌;葉耀宗; Hou, Ming-Feng;Chang, Chien-Wei;Chen, Fang-Ming;Wang, Shen-Nien;Yang, Sheau-Fang;Chen, Po-Han;Su, Jinu-Huang;Yeh, Yao-Tsung |
| 高雄醫學大學 |
2012 |
Phosphorylated p38 and JNKMAPK proteins in hepatocellular carcinoma
|
王森稔;李金德;Tsai, Chia-Jung;Chen, Yu-Jie;葉耀宗; Wang, Shen-Nien;Lee, King-Teh;Tsai, Chia-Jung;Chen, Yu-Jie;Yeh, Yao-Tsung |
| 輔英科技大學 |
2011-02-09 |
利用細胞及動物模式鑑定擬胜?抗癌藥物的結構與活性關係 (PI, NTD 1780,000)
|
葉耀宗 |
| 輔英科技大學 |
2010-08-01 |
研究組蛋白去乙醯脢和雌激素受體間之互動及其在乳癌治療及預後之可行性
|
葉耀宗;侯明鋒;楊曉芳 |
| 輔英科技大學 |
2010-08-01 |
結合臨床實證及基礎研究探討DNA修復蛋白質RAD51在肝癌的角色及應用
|
葉耀宗;李金德;楊曉芳;王森稔 |
| 輔英科技大學 |
2010-08-01 |
從臨床到基礎研究綜觀脂聯素(Adiponectin)對肝癌的影響
|
葉耀宗;王森稔 |
| 輔英科技大學 |
2010-08-01 |
MKP1/DUSP1在乳癌的機制探討與潛在性應用
|
葉耀宗;陳芳銘;楊曉芳;侯明鋒 |
| 輔英科技大學 |
2010-03-23 |
Histone deacetylase 6 was associated with overall survival rate in progesterone receptor-negative breast cancer.
|
葉耀宗 |
| 輔英科技大學 |
2010-03-23 |
Molecular pathways and therapeutic targets of adiponectin in Hepatocellular carcinoma.
|
葉耀宗 |
| 輔英科技大學 |
2009-12-09 |
Promoter methylation and phosphorylation status of PTEN in Taiwanese breast cancer
|
葉耀宗 |
| 輔英科技大學 |
2009-09-12 |
The potential role of MKP-1 for breast cancer prognosis prediction and therapeutic strategy selection
|
葉耀宗 |
| 輔英科技大學 |
2009-08-01 |
以DNA修復蛋白質Nibrin/NBS1在肝癌發展中扮演的角色及致癌機轉開發原型標靶藥物
|
葉耀宗;楊曉芳;王森稔 |
| 輔英科技大學 |
2009-03-25 |
Development of a novel peptide drug targeting MDM2 in hepatocellular carcinoma.
|
葉耀宗 |
| 輔英科技大學 |
2009-03-22 |
The role of suppressor of cytokine signaling 3 in breast cancer .
|
葉耀宗 |
| 輔英科技大學 |
2009-03-22 |
The role of protein inhibitor of activated STAT3 in breast cancer.
|
葉耀宗 |
| 輔英科技大學 |
2009-03-15 |
Dual Role of RAD51 in Hepatocellular Carcinoma. Extrinsic Control of Tumor Genesis and Progression.
|
葉耀宗 |
| 義守大學 |
2009 |
乳癌中的Mre11/Rad50/NBS1複合體---基礎研究及臨床應用
|
袁行修;侯明鋒;葉耀宗 |
| 高雄醫學大學 |
2009 |
The role of protein inhibitor of activated STAT3 in breast cancer
|
侯明鋒;陳柏翰;袁行修;歐陽賦;陳芳銘;陳懿芬;葉耀宗 |
| 高雄醫學大學 |
2009 |
The role of suppressor of cytokine signaling 3 in breast cancer
|
侯明鋒;陳柏翰;Yang, Hsiang-Jen;歐陽賦;陳芳銘;袁行修;陳懿芬;葉耀宗 |
| 義守大學 |
2008/03/01 |
Stryer's生物化學：第六版
|
偉鴻;吳佩姿 ;林凱元;莊國賓;許祥純;陳建成;陳彥元;陳師瑩;陳麗琴;葉耀宗;劉坤湘;譚誠明;楊文仁;謝寶萱;洪志勳 |
| 義守大學 |
2008/03/01 |
Stryer's生物化學：第六版
|
伍偉鴻;吳佩姿;林凱元;洪志勳;莊國賓;許祥純;陳建成;陳彥元;陳師瑩;陳麗琴;楊文仁;葉耀宗;謝寶萱;劉坤湘;譚誠明 |
| 輔英科技大學 |
2008-09-06 |
Altered HDAC6 Expression Is Associated with Progesterone Receptor Status And Overall Survival Rate in Breast Cancer.
|
葉耀宗 |
| 輔英科技大學 |
2008-09-06 |
Genotype Polymorphisms of CYP17, CYP1A1, and COMT in Very Young Breast Cancer.
|
葉耀宗 |
| 輔英科技大學 |
2008-09-06 |
Altered HDAC8 Expression Is Associated with Tumor Grading and Overall Survival Rate in Breast Cancer.
|
葉耀宗 |
| 輔英科技大學 |
2008-08-01 |
壓力活化蛋白質激脢之訊息傳遞在乳癌發生中所扮演之角色---臨床應用與基礎研究
|
葉耀宗;袁行修;侯明鋒;楊曉芳;王森稔;蘇鈞煌 |
| 輔英科技大學 |
2008-08-01 |
乳癌中的Mre11/Rad50/NBS1複合體---基礎研究及臨床應用
|
葉耀宗;袁行修;侯明鋒 |
| 輔英科技大學 |
2008-05-01 |
開發癌症診斷晶片全球化網路系統暨其自動化檢測工具之研發
|
曹德安;葉耀宗 |
| 輔英科技大學 |
2008-03-30 |
Altered HDAC2 Expression Is Associated with Estrogen Receptor expression in Breast Cancer.
|
葉耀宗 |
| 輔英科技大學 |
2008-03-30 |
Altered MKP-1 Expression Is Associated with Estrogen Receptor expression and Overall Survival Rate in Breast Cancer.
|
葉耀宗 |
| 輔英科技大學 |
2008-03-01 |
Stryer生物化學(Biochemistry, 6/e)
|
Jeremy M. Berg;John L. Tymoczko;Lubert Stryer;伍偉鴻;吳佩姿;林凱元;洪志勳;莊國賓;許祥純;陳建成;陳彥元;陳師瑩;陳麗琴;楊文仁;葉耀宗;謝寶萱;劉坤湘;譚誠明 |
| 高雄醫學大學 |
2008 |
Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
|
張雪玲;蘇鈞煌;葉耀宗;袁行修; Chang, HL;Wu, YC;Su, JH;Yeh, YT;Yuan, SS |
| 義守大學 |
2008 |
乳癌中的Mre11/Rad50/NBS1複合體---基礎研究及臨床應用
|
袁行修;侯明鋒;葉耀宗 |
| 高雄醫學大學 |
2008 |
解除組織蛋白deacetylase 2 可改變乳癌女性賀爾蒙接受器
|
侯明鋒;葉耀宗;歐陽賦;謝宗樺;袁行修;陳芳銘 |
| 高雄醫學大學 |
2008 |
Altered HDAC2 Expression Is Associated with Estrogen Receptor expression in Breast Cancer
|
葉耀宗;謝宗樺;李姿蓓;歐陽賦;陳芳銘;袁行修;侯明鋒 |
| 高雄醫學大學 |
2008 |
Altered MKP-1 Expression Is Associated with Estrogen Receptor expression and Overall Survival Rate in Breast Cancer
|
葉耀宗;楊翔荏;歐陽賦;陳懿芬;陳芳銘;袁行修;侯明鋒 |
| 高雄醫學大學 |
2008 |
HDAC6表現量的改變與黃體激素接受體的表現狀態及乳癌之整體存活率有關
|
侯明鋒;謝宗樺;歐陽賦;陳芳銘;袁行修;陳懿芬;謝淑娟;阮瓊慧;葉耀宗 |
| 高雄醫學大學 |
2008 |
HDAC8表現量的改變與腫瘤惡性程度分級及乳癌之整體存活率有關
|
葉耀宗;謝宗樺;陳柏翰;歐陽賦;陳芳銘;袁行修;陳懿芬;謝淑娟;阮瓊慧;侯明鋒 |
| 輔英科技大學 |
2007-10-14 |
Adiponectin is associated with viral hepatocellular carcinoma. Frontiers in Gastrointestinal Cancer: Molecular Genetics, Inflammation, Early Detection and Therapy
|
葉耀宗 |
| 輔英科技大學 |
2007-09-01 |
壓力活化蛋白質激脢(Stress Activated Protein Kinase, SAPK)之訊息傳遞及其與性腺賀爾蒙的交互作用在乳癌發生中所扮演之角色及其機制探討
|
葉耀宗;王森稔;袁行修;楊曉芳;侯明鋒 |
| 輔英科技大學 |
2007-08-08 |
Interplay of BRCA1, ER, and Repair Proteins in Breast Cancer.
|
葉耀宗 |
